Alternative Medicine Business Investment Opportunities in Thailand

Bangkok-based private limited company, established 5 years ago, is a dynamic and forward-thinking scientific distributor focused on distributing lab equipment, chemicals, biotech R&D services, and herbal health products. - The company has primarily been involved in importing and distribution, mainly sourcing products from the USA and China, and is now ready to transition into becoming manufacturer and exporter. - They are proud to be authorized distributors of world-renowned brands such as Sino Biological, FineTest, TargetMol, ELK Biotechnology, Reed Biotech, and BioBase, ensuring clients access to globally recognized products at competitive prices. - The company's mission is to bridge science with innovation by providing high-quality laboratory equipment, biological reagents, and herbal-based health products to research institutions, healthcare providers, universities, and the broader scientific community. - With previous annual sales of approximately THB 2 million and recent monthly sales of THB 429k, the business maintains a strong EBITDA margin of over 40%. - We now seek investment to scale operations by building a new GMP-compliant factory in Suphanburi province, to expand production capabilities and meet the rising global demand for natural and scientific products. - In the next year, operations will expand with a GMP-compliant factory focused on manufacturing herbal medicines, natural extracts, food and cosmetic ingredients, aligning with global quality and safety standards. - For the new GMP factory, we plan to buy land and construct a new facility on 9 rai of land in Suphanburi province. The company plans to start with a small-scale project, allowing for scalability in the future. - The company holds key licenses, including: 1. Food import license. 2. Cosmetic import license. 3. Medical device import license. Most importantly, we hold a Thai Traditional Medicine license, which is essential for establishing and running a Thai herbal factory. - Led by a visionary founder, the company offers strategic, silent, or foreign investment roles, providing opportunities for high returns and international expansion. We are committed to: 1. Supporting scientific research and education. 2. Promoting natural health innovation. 3. Offering outstanding service with local insight and global quality. The company aims to become a trusted partner in advancing science, health, and sustainability, locally and internationally.

We are an innovative company specialized in silicone development for healthcare and pharmaceutical area, established in 2009. We have been selling and exporting to many countries in Asia with our own patents and trade marks. The sales growing well each year so, when the sales increase the investment for funding support are needed. The reason for the loan is to support cash flow and stock inventory. Major products such as silicone gel for scar reduction, Asian formula, and silicone gel sheet for scars. Kelosil silicone gel plus CBD, we are the only one who can combine CBD (cannabidiol into silicone gel with transparent texture, which will a new evolution of silicone gel for wound healing and scar reductuion products. The new invention for cannabis (CBD) product development, we are brand owner of CBD products such as CBD cream, CBD drinks, Estimate Sales (year sales) 2022 = 44,000 USD. 2023 = USD 55,000. 2024 = USD 100,000. 2025 = USD 150,000. 2026 = USD 300,000.

We plan to cultivate cannabis for medical purpose. We are yet to register our company. - Soon the company will have the ability to vegetate up to 1,500 plants and flowers concurrently. - We will grow up to 4 different strains of marijuana and will be able to grow from seedling to finished product. - We will dry and process all cannabis into labelled/inventoried vacuum-sealed bags before delivery. - The company will distribute products through wholesale transactions to qualified, licensed marijuana establishments. - From a total investment of $250 thousand, company is expected to generate nearly $660 thousand in gross revenues with a pre-tax income of nearly $1.5 million in year 3, its first full year of operations. - Revenue is expected to grow to nearly $3 million in year 4 and $5.9 million in year 5. - Promoter is based in the Philippines and the business will be operational in Thailand. - Image uploaded in the profile is a stock photo.

We plan to cultivate cannabis for medical purpose. We are yet to register our company. - Soon the company will have the ability to vegetate up to 1,500 plants and flowers concurrently. - We will grow up to 4 different strains of marijuana and will be able to grow from seedling to finished product. - We will dry and process all cannabis into labelled/inventoried vacuum-sealed bags before delivery. - The company will distribute products through wholesale transactions to qualified, licensed marijuana establishments. - From a total investment of $250 thousand, company is expected to generate nearly $660 thousand in gross revenues with a pre-tax income of nearly $1.5 million in year 3, its first full year of operations. - Revenue is expected to grow to nearly $3 million in year 4 and $5.9 million in year 5. - Promoter is based in the Philippines and the business will be operational in Thailand. - Image uploaded in the profile is a stock photo.